e-learning
resources
Milan 2017
Tuesday, 12.09.2017
MDRTB: detection and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment outcomes in patients with multidrug-resistant tuberculosis in Japan, 2011-2013
N. KOBAYASHI (Kiyose, Tokyo, Japan)
Source:
International Congress 2017 – MDRTB: detection and management
Session:
MDRTB: detection and management
Session type:
Poster Discussion
Number:
3494
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. KOBAYASHI (Kiyose, Tokyo, Japan). Treatment outcomes in patients with multidrug-resistant tuberculosis in Japan, 2011-2013. 3494
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004
Source: Eur Respir J 2010; 36: 584-593
Year: 2010
Treatment outcome of XDR-TB patients in Iran during 2003-2006
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008
Our experience and treatment results of multidrug-resistant tuberculosis (MDR-TB) patients between 1996-2002
Source: Eur Respir J 2003; 22: Suppl. 45, 42s
Year: 2003
Treatment outcomes of MDR-TB patients notified in Romania during 2005-2007
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013
Management of MDR and rifampicin-resistant TB cases in Italy, 1995-1999
Source: Eur Respir J 2001; 18: Suppl. 33, 513s
Year: 2001
Characteristics of XDR-TB patients in Israel: 2000-2010
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Treatment outcome in multidrug resistant tuberculosis cases at our clinic between 1996-2008
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
Treatment outcome and factors associated with unfavourable treatment results in cases with multidrug-resistant tuberculosis in Bulgaria for the period 2009-2010
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
Treatment of tuberculosis in Hungary in 2003
Source: Eur Respir J 2004; 24: Suppl. 48, 652s
Year: 2004
Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
High proportion of fluoroquinolone mono-resistant
mycobacterium tuberculosis
(MTB) strains in Pakistan (2010-2012)
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Multidrug–resistant tuberculosis in Czech Republic during the period of recent 5 years (2007-2012)
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Treatment outcomes of smear-positive pulmonary TB cases in Romania in 2006-2008
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Epidemiology of tuberculosis (TB) in Poland in the period 1994-2003
Source: Eur Respir J 2005; 26: Suppl. 49, 191s
Year: 2005
Characteristics of patients under treatment for NTM disease during the period 2004-2013 in Greece
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
The epidemiological characteristics of tuberculosis (TB) in Romania between 2000-2008
Source: Annual Congress 2010 - Tuberculosis epidemiology
Year: 2010
Mortality and associated factors among drug-resistant tuberculosis patients in Portugal, 2000-2016
Source: Virtual Congress 2020 – Tuberculosis: part 2
Year: 2020
Drug resistance of mycobacterium tuberculosis isolates in Serbia over five-year period (2001-2005)
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008
Treatment outcomes of MDR-TB cases registered in Bucharest sector 4 during 2004-2008
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept